The Global Aminoglycosides Market size is expected to reach USD 2.13 Billion by 2028 and register a CAGR of 3.7%, according to the latest report by Reports and Data. Aminoglycoside drugs are used for the treatment of various bacterial infections in humans and animals. Application of this class of drug for defense against infection resistance and as antibacterials drive the growth of the market. Increase in the number of people suffering from tuberculosis across the globe is also encouraging the growth of the market. The presence of UNITAID and Global Drug Facility is further anticipated to fuel the market growth. These organizations serve as an intervention for the diagnosis and management of tuberculosis. Rising cases of MDR-TB and yearly procurement requirement by GDF and STOP TB foundation is further anticipated to boost the market.

Side effects associated with the drugs such as irreversible hearing loss, muscle twitching, and seizure will hinder the growth of the market. The decrease in sales of a certain type of aminoglycosides will also limit the market.

Top Companies Profiled in the Report Include:

Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Taiwan Fructose, Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd.

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the aminoglycosides market in these key regions.

Country-wise regional analysis covers:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • BENELUX
  • Italy
  • Spain
  • Switzerland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Turkey
  • Rest of MEA

Additionally, the report consists a detailed analysis of the segmentation of the aminoglycosides market based on product types and end-use/application offered in the aminoglycosides market.

Drug Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2028)

• Neomycin
• Tobramycin
• Gentamicin
• Amikacin
• Paromomycin
• Streptomycin
• Kanamycin

Mode of Administration Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2028)

• Feed
• Injectable
• Intra-mammary
• Topical
• Oral

Application Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2028)

• Veterinary
• Skin
• Respiratory
• UTI Pelvic Disease
• Neonatal Sepsis

Distribution Channel Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2028)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Clinics

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.